TetraLogic Pharmaceuticals Corporation
TLOG
$0.00
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Net Income | 20.76% | 43.18% | 12.75% | -19.53% | -16.78% |
| Total Depreciation and Amortization | -80.71% | -54.76% | 66.44% | 14.73% | 39.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.17% | 41.12% | -26.94% | 78.32% | 317.09% |
| Change in Net Operating Assets | 206.07% | -122.00% | 40.32% | 100.33% | -58.36% |
| Cash from Operations | 63.60% | 45.63% | 16.64% | 18.73% | 2.09% |
| Capital Expenditure | -- | -- | -- | 99.36% | 9.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -57.23% | 14.01% | 156.98% |
| Cash from Investing | -100.00% | -100.00% | -55.83% | 15.70% | 156.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | 103.08% | 95.32% | -50.70% | 324.33% | -219.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.38% | -29.42% | -119.52% | 84.61% | 114.95% |